IGM Biosciences Inc (IGMS)
9.45
-0.18
(-1.87%)
USD |
NASDAQ |
May 01, 16:00
9.465
+0.02
(+0.16%)
After-Hours: 20:00
IGM Biosciences Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2022
--
Maximum
Jun 2022
--
Average
--
Median
Jun 2022
Total Long Term Debt (Quarterly) Benchmarks
Inotiv Inc | 379.34M |
Synlogic Inc | 0.00 |
BioXcel Therapeutics Inc | 100.60M |
Xilio Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 1.137M |